Echocardiography-guided percutaneous intramyocardial alginate hydrogel implants for heart failure: canine models with 6-month outcomes

Frontiers in Cardiovascular Medicine(2024)

引用 0|浏览2
暂无评分
摘要
Background: Echocardiography -guided percutaneous intramyocardial alginatehydrogel implantation (PIMAHI) is a novel treatment approach for heart failure (HF). We validated PIMAHI safety and efficacy in canine HF models. Methods: Fourteen canines with HF [produced by coronary artery ligation, left ventricular ejection fraction (LVEF) < 35%] were randomised to PIMAHI treatment (n = 8) or controls (n = 6). Echocardiography, two-dimensional speckle tracking echocardiography, and pathological examinations after a 6month follow-up were performed. Repeated -measures analysis of variance was used for within -group comparisons. Results: At 6 -month follow-up, PIMAHI treatment reversed LV dilation and remodelling, increasing LV free wall thickness (LVFW, p = 0.002) and interventricular septum thickness (IVS, p < 0.001) and reducing LV end -diastolic volume (EDV, p = 0.008) and end -systolic volume (ESV, p = 0.004). PIMAHI significantly improved LV systolic function, increasing LVEF (EF, p = 0.004); enhanced LV myocardial contractility, including increased LV global longitudinal strain (GLS, p < 0.001), global circumferential strain (GCS, p = 0.006), and mitral annulus displacement (MAD, p = 0.001). Compared with controls at 6 -month, PIMAHI group significantly increased LVFW thickness (8.5 +/- 0.3 vs. 6.8 +/- 0.2 mm, p = 0.002) and IVS (7.9 +/- 0.1 vs. 6.1 +/- 0.2 mm, p < 0.001); decreased LVEDV (30.1 +/- 1.6 vs. 38.9 +/- 4.5 ml, p = 0.049) and ESV (17.3 +/- 1.2 vs. 28.7 +/- 3.6 ml, p = 0.004); increased LV systolic function (42.7 +/- 1.5 vs. 26.7 +/- 1.1% in EF, p = 0.001); and enhanced LV myocardial contractility including GLS (13.5 +/- 0.8 vs. 8.4 +/- 0.6%, p = 0.002), GCS (16.5 +/- 1.4 vs. 9.2 +/- 0.6%, p = 0.001), and MAD (11.4 +/- 3.5vs 4.6 +/- 2.5 mm, p = 0.003). During PIMAHI treatment, no sustained arrhythmia, pericardial, or pleural effusion occurred. Conclusions: PIMAHI in canine HF models was safe and effective. It reversed LV dilation and improved LV function.
更多
查看译文
关键词
percutaneous intramyocardial alginate hydrogels implants,heart failure,animal models,left ventricular function,myocardial contractility
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要